Targeting pathogenic TAR DNA-binding protein 43 to treat frontotemporal dementia and motor neuron disease [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Frontotemporal dementia and motor neuron Disease are rapidly progressive and fatal neurodegenerative diseases that affect people in their prime. Poor understanding of the processes that lead to these diseases have slowed drug development. Through innovative experimental design, we aim to decipher a novel disease mechanism that involves specific molecular interactions and translate these findings into new therapies for the diseases.

Funding Amount $687,444

Funding Scheme Ideas Grants

Chief Investigator A/Pr Yazi Ke

Notes Ideas Grants